![Mark L. Lewis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark L.
Lewis is currently the Executive Chairman at Miroculus, Inc. He previously worked as the Director at Swift Biosciences, Inc. from 2017 to 2021.
He also held the position of General Manager & Vice President at BD Biosciences Clontech.
Aktive Positionen von Mark L. Lewis
| Unternehmen | Position | Beginn |
|---|---|---|
Miroculus, Inc.
 Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Vorsitzender | 19.04.2022 |
Ehemalige bekannte Positionen von Mark L. Lewis
| Unternehmen | Position | Ende |
|---|---|---|
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Vorstandsvorsitzender | 01.01.2018 |
BD Biosciences Clontech
 BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BD Biosciences Clontech
BD Biosciences Clontech BiotechnologyHealth Technology Develops microarray products | Health Technology |
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Develops molecular biology reagents | Health Technology |
Miroculus, Inc.
Miroculus, Inc. Packaged SoftwareTechnology Services Develops software tools for biotechnology company | Technology Services |
